Clinical Trial

Safety and Efficacy of the RENATUS® Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a prospective, non-randomized, observational, post-market follow-up trial designed to evaluate the safety and efficacy of the RENATUS® Transcatheter Aortic Valve System for the treatment of severe aortic stenosis.
Trial Details
NCT Number NCT07414342
Lead Sponsor Beijing Balance Medical Technology Co., Ltd
Conditions Severe Aortic Stenosis
Enrollment 800 participants
Start Date 2026-02
Primary Completion 2027-09 (estimated)
Study Completion 2037-09 (estimated)
Updated on ClinicalTrials.gov 2026-02-17